已收录 273693 条政策
 政策提纲
  • 暂无提纲
Thienopyridine Resistance Among Patients Undergoing Intracoronary Stent Implantation and Treated With Dual Antiplatelet Therapy: Assessment of Some Modifying Factors
[摘要] References(15)Cited-By(5)In this open, prospective study we assessed the prevalence of antiplatelet resistance among patients subjected to intracoronary stent implantation. In patients treated with aspirin + thienopyridine (N = 32), platelet reactivity index (PRI) significantly decreased after 2 and 7 days of dual antiplatelet treatment in comparison with the same patients on aspirin monotherapy (P<0.001, both). After 7 days of aspirin + thienopyridine treatment, insufficient antiplatelet response was observed in 28% (9/32) of the patients. High interindividual variability in response to aspirin + thienopyridine treatment emphasizes the significance of thienopyridine resistance, while the influence of statins on such a treatment should be reassessed.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药学
[关键词] antiplatelet agent;stent;vasodilator-stimulated phosphoprotein (VASP) assay [时效性] 
   浏览次数:7      统一登录查看全文      激活码登录查看全文